GUANRANDA Trademark

Trademark Overview


On Thursday, August 27, 2020, a trademark application was filed for GUANRANDA with the United States Patent and Trademark Office. The USPTO has given the GUANRANDA trademark a serial number of 90140779. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 5, 2022. This trademark is owned by BRIOPRYME BIOLOGICS, INC.. The GUANRANDA trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in treating or diagnosing wounds; medical devices for use in treating or diagnosing wounds; medical devices for use in medical devices for use in ophthalmology, tumor resection, ulcer surgeries; medical apparatus, instruments and devices for use in abdominal, pelvic, spinal, orthopedic, cardio-vascular, ophthalmology, and dermatology procedures; medical apparatus, instruments and devices for use in drug, stem cell or growth-factor delivery, namely, water-soluble and injectable hydrogel carrier devices sold empty for drug, stem cell or growth-factor delivery; medical apparatus, instruments and devices for use in management of wounds and in management of and relief of the pain induced by various treatment of cancer including but not limited to chemoradiotherapy, immunotherapy or targeted therapy
guanranda

General Information


Serial Number90140779
Word MarkGUANRANDA
Filing DateThursday, August 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 9, 2021

Trademark Statements


Goods and ServicesMedical apparatus and instruments for use in treating or diagnosing wounds; medical devices for use in treating or diagnosing wounds; medical devices for use in medical devices for use in ophthalmology, tumor resection, ulcer surgeries; medical apparatus, instruments and devices for use in abdominal, pelvic, spinal, orthopedic, cardio-vascular, ophthalmology, and dermatology procedures; medical apparatus, instruments and devices for use in drug, stem cell or growth-factor delivery, namely, water-soluble and injectable hydrogel carrier devices sold empty for drug, stem cell or growth-factor delivery; medical apparatus, instruments and devices for use in management of wounds and in management of and relief of the pain induced by various treatment of cancer including but not limited to chemoradiotherapy, immunotherapy or targeted therapy

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 1, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBRIOPRYME BIOLOGICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFolsom, CA 95630

Party NameBRIOPRYME BIOLOGICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFolsom, CA 95630

Trademark Events


Event DateEvent Description
Monday, December 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 28, 2022SOU EXTENSION 2 GRANTED
Thursday, April 28, 2022SOU EXTENSION 2 FILED
Thursday, April 28, 2022TEAS EXTENSION RECEIVED
Saturday, November 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 4, 2021SOU EXTENSION 1 GRANTED
Thursday, November 4, 2021SOU EXTENSION 1 FILED
Thursday, November 4, 2021TEAS EXTENSION RECEIVED
Tuesday, May 4, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 1, 2021EXAMINER'S AMENDMENT ENTERED
Monday, February 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 1, 2021EXAMINERS AMENDMENT E-MAILED
Monday, February 1, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 29, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 29, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 29, 2020ASSIGNED TO EXAMINER
Thursday, October 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 31, 2020NEW APPLICATION ENTERED IN TRAM